PDA TR 81 focuses on the development of a risk-based control strategy adapted to cell-based therapy that can mitigate the risk of generating a product of poor quality.
Original price was: $325.00.$162.00Current price is: $162.00.
Technical Report No. 81 (TR 81) Cell-Based Therapy Control Strategy
Parenteral Drug Association , 2019
Pages: 58
Related products
-
PDA TR 52
Original price was: $325.00.$162.00Current price is: $162.00. -
PDA TR 48
Original price was: $325.00.$162.00Current price is: $162.00. -
PDA TR 54-3
Original price was: $325.00.$162.00Current price is: $162.00. -
PDA TR 22
Original price was: $325.00.$162.00Current price is: $162.00. -
PDA TR 59
Original price was: $325.00.$162.00Current price is: $162.00.